{
    "uuid": "dnd-W3647-04A501\/001\/PV",
    "vendorName": "GlaxoSmithKline Inc.",
    "referenceNumber": "W3647-04A501\/001\/PV",
    "contractDate": "10-6-2004",
    "description": "Drugs and Biologicals",
    "extraDescription": "",
    "objectCode": "",
    "contractPeriodStart": "",
    "contractPeriodEnd": "",
    "startYear": 2004,
    "endYear": 2004,
    "deliveryDate": "30-6-2004",
    "originalValue": 0,
    "contractValue": 126000,
    "comments": "",
    "ownerAcronym": "dnd",
    "sourceYear": 2004,
    "sourceQuarter": 1,
    "sourceFiscal": "200405-Q1",
    "sourceFilename": "dnd\/923d32123badef7f84d1e831c9997ced.html",
    "sourceURL": "http:\/\/www.admfincs.forces.gc.ca\/apps\/dc\/contract-contrat-eng.asp?q=1&y=2004&id=id3640",
    "vendorClean": "GLAXOSMITHKLINE"
}